KTC
AZN icon

Kentucky Trust Company’s AstraZeneca AZN Stock Holding History

Kentucky Trust Company’s Portfolio AZN Stock Details AZN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-53
Closed -$9.74K – 313
2025
Q4 		$9.74K Buy
+53
New +$9.29K 0.01% 255

Other funds holding AZN

IA
Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
VAM
Vanguard Asset Management London, Ec4n 8af $117B AUM

Kentucky Trust Company's AZN Position: Q1 2026 in Review

Kentucky Trust Company sold out of AstraZeneca (AZN) in Q1 2026, closing a stake of 53 shares — an estimated $9.74K sold.

Kentucky Trust Company first reported a position in AZN in Q4 2025 and held it in 1 quarter. The position peaked at $9.74K in Q4 2025. 1,381 funds tracked by Wall St. Rank hold AZN as of Q1 2026.

  • Kentucky Trust Company reported no remaining AstraZeneca position as of Q1 2026 after selling out during the quarter.
  • Kentucky Trust Company sold 53 AstraZeneca shares in Q1 2026, an estimated $9.74K.
  • Kentucky Trust Company first reported a position in AstraZeneca in Q4 2025 and held it in 1 quarter.
  • Kentucky Trust Company's AstraZeneca position peaked at $9.74K in Q4 2025.
  • 1,381 funds tracked by Wall St. Rank held AstraZeneca as of Q1 2026.

Based on Kentucky Trust Company's 13F filing for Q1 2026, filed 17 Apr 2026.